2 completed, 2 unknown, 1 active not recruiting, 1 not yet recruiting. 7 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 2, Unknown 2, Active not recruiting 1, Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Nicorandil: new trials by email Literature Review of Nicorandil trials Research Report on Nicorandil
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Impact of Using Nicorandil for the Prevention of Doxorubicin-Induced Cardiotoxicity Nicorandil Oral Tablet, Adriamycin (Doxorubicin) - Doxorubicin Induced Cardiotoxicity, Doxorubicin Induced Cardiomyopathy | Phase 2 | Not yet recruiting | Universiti Sains Malaysia | 146 | 2026-12-01 | 2026-11-03 |
| The Effect of Nicorandil on Rheumatoid Arthritis Patients Nicorandil Oral Tablet, Placebo, conventional synthetic antirheumatic drugs (cDMARDs) - Rheumatoid Arthritis (RA) | Phase 2 / Phase 3 | Recruiting | Ain Shams University | 70 | 2026-09-06 | 2026-09-16 |
| Oral Nicorandil for Prevention of No Reflow Phenomenon in Anterior STEMI Patients Undergoing PPCI Nicorandil 20mg - No Reflow Phenomenon, Anterior STEMI | Phase 1 / Phase 2 | Completed | Ain Shams University | 300 | 2024-03-10 | 2025-08-24 |
| Effect of Nicorandil in Type 2 Diabetic Obese Patients Nicorandil 10 MG - Diabetes Mellitus, Type 2 | Phase 2 | Completed | Tanta University | 46 | 2023-11-01 | 2026-08-12 |
| Intracoronary of Nicorandil and Verapamil to Reduce the Occurrence of Periprocedural Myocardial Injury Nicorandil, Saline - Coronary Artery Disease | Phase 2 | Unknown | The First Affiliated Hospital of Zhejiang Chinese Medical University | 150 | 2022-05-17 | 2022-06-01 |
| Safety and Modulation of ABCC9 Pathways by Nicorandil for the Treatment of Hippocampal Sclerosis of Aging Nicorandil, Placebo - Dementia, Mild Cognitive Impairment | Phase 2 | Active not recruiting | Gregory Jicha, MD, PhD | 64 | 2021-12-01 | 2025-12-15 |
| Mitigation of Radiation Pneumonitis, Fibrosis and Heart Toxicity With Nicorandil in Lung Cancer Patients Nicorandil - Radiation Pneumonitis | Phase 2 | Unknown | Taipei Medical University WanFang Hospital | 50 | 2016-07-01 | 2016-06-23 |
Arthritis, Rheumatoid (1) · Autoimmune Diseases (1) · Cardiomyopathies (1) · Cardiotoxicity (1) · Cognitive Dysfunction (1) · Coronary Artery Disease (1) · Dementia (1) · Diabetes Mellitus, Type 2 (1) · Hippocampal Sclerosis (1) · Inflammation (1) · No-Reflow Phenomenon (1) · Obesity (1) · Radiation Pneumonitis (1)
Ain Shams University (2) · Gregory Jicha, MD, PhD (1) · Taipei Medical University WanFang Hospital (1) · Tanta University (1) · The First Affiliated Hospital of Zhejiang Chinese Medical University (1) · Universiti Sains Malaysia (1)
Egypt (4) · China (1) · United States (1)
Ayman A G, Prof (1) · Gregory A Jicha, MD, PhD (1) · May A. Shawky, Assoc. Prof. (1) · Nagwa A. Sabri, Professor (1) · Noha S Abdelaziz, PhD (1) · Nur H Md, lecturer (1) · Sabariah N H, Ass.Prof (1)
R01AG061111 (1)